Overview

Sir John Bertrand Gurdon (born 2 October 1933) is a British developmental biologist best known for demonstrating that the nucleus of a mature, specialised cell can be returned to an embryonic state. His experiments showed that differentiated cells retain the full genetic information needed to direct development. For this body of work he shared the 2012 Nobel Prize in Physiology or Medicine and has been widely recognised for shaping modern stem cell biology. See a short profile of his role as a scientist: biographical note.

Nuclear transplantation and somatic cell nuclear transfer

Nuclear transplantation — often called somatic cell nuclear transfer (SCNT) — is a laboratory technique in which the nucleus is removed from a donor cell and transferred into an egg cell whose own nucleus has been removed. The goal is to reprogramme the donor nucleus so that it begins to direct development as if it were embryonic. The term "nucleus" and its cellular role are explained in many basic references: nucleus overview.

Early experiments and significance

In the early 1960s Gurdon used frog eggs to show that nuclei from differentiated intestinal cells could be transplanted into enucleated eggs and support the development of tadpoles. These results overturned the then-common belief that differentiation involved irreversible loss of genetic information. His work provided strong experimental evidence for nuclear equivalence — the idea that most cells keep the same genetic blueprint — and introduced the concept of cellular reprogramming.

Technique, characteristics and steps

  • Enucleation: remove the egg cell's nucleus to create an environment free of maternal genetic material.
  • Nuclear transfer: insert a nucleus taken from a specialised somatic cell into the enucleated egg.
  • Activation and culture: stimulate the reconstructed egg to begin dividing and observe development in tissue culture or an appropriate host system; see basic methods in tissue culture guides.

Impact, extensions and ethical context

Gurdon's discoveries paved the way for cloning efforts and for later strategies to create pluripotent stem cells. In 2006–2007 Shinya Yamanaka developed methods to produce induced pluripotent stem cells (iPSCs) by introducing defined factors into adult cells; this advance extended the theme of reprogramming and together with Gurdon's results earned a shared Nobel Prize. The techniques inspired both therapeutic research (regenerative medicine) and ethical debates around cloning and embryo use. The broader concept of using specialised cells for regenerative therapies remains a central goal of the field: background on somatic cell concepts is available here: somatic cell resources.

Legacy

Gurdon's experiments are regarded as a turning point in developmental biology. Beyond the Nobel, his influence includes training generations of researchers, shaping policies on cloning and stem cells, and motivating new technologies that probe how cell identity is encoded and changed. His work continues to inform basic science and applied biomedical research aimed at replacing or repairing damaged tissues.